A randomized, double-blind trial comparing the effect of mixing propofol with either lidocaine or nafamostat mesilate on injection pain

Eriksson M., Englesson S., Niklasson F., Hartvig P., Effects of lignocaine and pH on propofol-induced pain, Br J Anaesth, 78, pp. 502-506, (1997)

Iwama H., Nakane M., Ohmori S., Kaneko T., Kato M., Watanabe K., Okuaki A., Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol, Br J Anaesth, 81, pp. 963-964, (1998)

Nakane M., Iwama H., A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate, Br J Anaesth, 83, pp. 397-404, (1999)

Hitomi Y., Ikari N., Fujii S., Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system, Haemostasis, 15, pp. 164-168, (1985)

Nathanson M.H., Gajraj N.M., Russell J.A., Prevention of pain on injection of propofol: A comparison of lidocaine with alfentanil, Anesth Analg, 82, pp. 469-471, (1996)

Okajima K., Uchiba M., Murakami K., Nafamostat mesilate, Cardiovasc Drug Rev, 13, pp. 51-65, (1995)

Hu Z.J., Iwama H., Suzuki R., Kobayashi S., Akutsu I., Time course of activated coagulation time at various sites during continuous haemodiafiltration using nafamostat mesilate, Intensive Care Med, 25, pp. 524-527, (1999)

Aoyama T., Nafamstat mesilate, Drugs of the Future, 9, pp. 747-748, (1984)

Maruyama H., Miyakawa Y., Gejyo F., Arakawa M., Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient, Nephron, 74, pp. 468-469, (1996)

Nanpo T., Ohtsuki T., Jin Y., Matsunaga K., Takahashi M., Shibuya M., Sasaki H., Kurumi M., Pharmacokinetic studies of FUT-175 (nafamstat mesilate) (1): Blood level profiles, tissue distribution, metabolism and excretion in rats after intravenous administration (in Japanese with English abstract), Kiso To Rinsho, 18, pp. 3971-3992, (1984)

Eriksson M., Englesson S., Niklasson F., Hartvig P., Effects of lignocaine and pH on propofol-induced pain, Br J Anaesth, 78, pp. 502-506, (1997)

Iwama H., Nakane M., Ohmori S., Kaneko T., Kato M., Watanabe K., Okuaki A., Nafamostat mesilate, a kallikrein inhibitor, prevents pain on injection with propofol, Br J Anaesth, 81, pp. 963-964, (1998)

Nakane M., Iwama H., A potential mechanism of propofol-induced pain on injection based on studies using nafamostat mesilate, Br J Anaesth, 83, pp. 397-404, (1999)

Hitomi Y., Ikari N., Fujii S., Inhibitory effect of a new synthetic protease inhibitor (FUT-175) on the coagulation system, Haemostasis, 15, pp. 164-168, (1985)

Nathanson M.H., Gajraj N.M., Russell J.A., Prevention of pain on injection of propofol: A comparison of lidocaine with alfentanil, Anesth Analg, 82, pp. 469-471, (1996)

Okajima K., Uchiba M., Murakami K., Nafamostat mesilate, Cardiovasc Drug Rev, 13, pp. 51-65, (1995)

Hu Z.J., Iwama H., Suzuki R., Kobayashi S., Akutsu I., Time course of activated coagulation time at various sites during continuous haemodiafiltration using nafamostat mesilate, Intensive Care Med, 25, pp. 524-527, (1999)

Aoyama T., Nafamstat mesilate, Drugs of the Future, 9, pp. 747-748, (1984)

Maruyama H., Miyakawa Y., Gejyo F., Arakawa M., Anaphylactoid reaction induced by nafamostat mesilate in a hemodialysis patient, Nephron, 74, pp. 468-469, (1996)

Nanpo T., Ohtsuki T., Jin Y., Matsunaga K., Takahashi M., Shibuya M., Sasaki H., Kurumi M., Pharmacokinetic studies of FUT-175 (nafamstat mesilate) (1): Blood level profiles, tissue distribution, metabolism and excretion in rats after intravenous administration (in Japanese with English abstract), Kiso To Rinsho, 18, pp. 3971-3992, (1984)